{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T13:59:56Z","timestamp":1781877596760,"version":"3.54.5"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T00:00:00Z","timestamp":1781827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T00:00:00Z","timestamp":1781827200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100008836","name":"Gaziantep \u00dcniversitesi","doi-asserted-by":"publisher","award":["TF.HZP.23.44"],"award-info":[{"award-number":["TF.HZP.23.44"]}],"id":[{"id":"10.13039\/501100008836","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biol Rep"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1007\/s11033-026-12183-1","type":"journal-article","created":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T13:50:20Z","timestamp":1781877020000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Neuroprotective effects of gallic acid in an MPP\u207a-induced SH-sy5y cell model of parkinson\u2019s disease"],"prefix":"10.1007","volume":"53","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3890-2088","authenticated-orcid":false,"given":"Hasan","family":"Ulusal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6780-229X","authenticated-orcid":false,"given":"Hatice Kubra Yigit","family":"Dumrul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0596-4178","authenticated-orcid":false,"given":"Sibel","family":"Dagli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9914-7122","authenticated-orcid":false,"given":"Mustafa","family":"Oztatlici","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2398-8264","authenticated-orcid":false,"given":"Mehmet","family":"Tarakcioglu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,19]]},"reference":[{"key":"12183_CR1","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1111\/ene.14108","volume":"27","author":"R Balestrino","year":"2020","unstructured":"Balestrino R, Schapira AHV (2020) Parkinson disease. Eur J Neurol 27:27\u201342. https:\/\/doi.org\/10.1111\/ene.14108","journal-title":"Eur J Neurol"},{"key":"12183_CR2","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1016\/j.amjmed.2019.03.001","volume":"132","author":"MT Hayes","year":"2019","unstructured":"Hayes MT (2019) Parkinson\u2019s Disease and Parkinsonism. Am J Med 132:802\u2013807. https:\/\/doi.org\/10.1016\/j.amjmed.2019.03.001","journal-title":"Am J Med"},{"key":"12183_CR3","doi-asserted-by":"publisher","unstructured":"Marogianni C, Sokratous M, Dardiotis E, Hadjigeorgiou GM et al (2020) Neurodegeneration and inflammation-an interesting interplay in parkinson\u2019s disease. Int J Mol Sci 21. https:\/\/doi.org\/10.3390\/ijms21228421","DOI":"10.3390\/ijms21228421"},{"key":"12183_CR4","doi-asserted-by":"publisher","first-page":"e23","DOI":"10.7417\/t.2018.2050","volume":"169","author":"MS Amro","year":"2018","unstructured":"Amro MS, Teoh SL, Norzana AG, Srijit D (2018) The potential role of herbal products in the treatment of Parkinson\u2019s disease. Clin Ter 169:e23\u2013e33. https:\/\/doi.org\/10.7417\/t.2018.2050","journal-title":"Clin Ter"},{"key":"12183_CR5","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/j.nbd.2017.04.004","volume":"109","author":"EM Rocha","year":"2018","unstructured":"Rocha EM, De Miranda B, Sanders LH (2018) Alpha-synuclein: Pathology, mitochondrial dysfunction and neuroinflammation in Parkinson\u2019s disease. Neurobiol Dis 109:249\u2013257. https:\/\/doi.org\/10.1016\/j.nbd.2017.04.004","journal-title":"Neurobiol Dis"},{"key":"12183_CR6","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/s0140-6736(23)01419-8","volume":"403","author":"Y Ben-Shlomo","year":"2024","unstructured":"Ben-Shlomo Y, Darweesh S, Llibre-Guerra J, Marras C et al (2024) The epidemiology of Parkinson\u2019s disease. Lancet 403:283\u2013292. https:\/\/doi.org\/10.1016\/s0140-6736(23)01419-8","journal-title":"Lancet"},{"key":"12183_CR7","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1016\/s0140-6736(14)61393-3","volume":"386","author":"LV Kalia","year":"2015","unstructured":"Kalia LV, Lang AE (2015) Parkinson\u2019s disease. Lancet 386:896\u2013912. https:\/\/doi.org\/10.1016\/s0140-6736(14)61393-3","journal-title":"Lancet"},{"key":"12183_CR8","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1080\/01616412.2016.1251711","volume":"39","author":"MT Islam","year":"2017","unstructured":"Islam MT (2017) Oxidative stress and mitochondrial dysfunction-linked neurodegenerative disorders. Neurol Res 39:73\u201382. https:\/\/doi.org\/10.1080\/01616412.2016.1251711","journal-title":"Neurol Res"},{"key":"12183_CR9","doi-asserted-by":"publisher","first-page":"236","DOI":"10.3389\/fnmol.2018.00236","volume":"11","author":"Z Wei","year":"2018","unstructured":"Wei Z, Li X, Li X, Liu Q, Cheng Y (2018) Oxidative Stress in Parkinson\u2019s Disease: A Systematic Review and Meta-Analysis. Front Mol Neurosci 11:236. https:\/\/doi.org\/10.3389\/fnmol.2018.00236","journal-title":"Front Mol Neurosci"},{"key":"12183_CR10","doi-asserted-by":"publisher","first-page":"e13031","DOI":"10.1111\/acel.13031","volume":"18","author":"BG Trist","year":"2019","unstructured":"Trist BG, Hare DJ, Double KL (2019) Oxidative stress in the aging substantia nigra and the etiology of Parkinson\u2019s disease. Aging Cell 18:e13031. https:\/\/doi.org\/10.1111\/acel.13031","journal-title":"Aging Cell"},{"key":"12183_CR11","doi-asserted-by":"publisher","unstructured":"Tchekalarova J, Tzoneva R (2023) Oxidative stress and aging as risk factors for alzheimer\u2019s disease and parkinson\u2019s disease: the role of the antioxidant melatonin. Int J Mol Sci 24. https:\/\/doi.org\/10.3390\/ijms24033022","DOI":"10.3390\/ijms24033022"},{"key":"12183_CR12","doi-asserted-by":"publisher","first-page":"1028","DOI":"10.1016\/j.foodchem.2012.11.022","volume":"138","author":"MT Mansouri","year":"2013","unstructured":"Mansouri MT, Farbood Y, Sameri MJ, Sarkaki A et al (2013) Neuroprotective effects of oral gallic acid against oxidative stress induced by 6-hydroxydopamine in rats. Food Chem 138:1028\u20131033. https:\/\/doi.org\/10.1016\/j.foodchem.2012.11.022","journal-title":"Food Chem"},{"key":"12183_CR13","doi-asserted-by":"publisher","first-page":"973256","DOI":"10.3389\/fped.2022.973256","volume":"10","author":"X Dong","year":"2022","unstructured":"Dong X, Luo S, Hu D, Cao R et al (2022) Gallic acid inhibits neuroinflammation and reduces neonatal hypoxic-ischemic brain damages. Front Pediatr 10:973256. https:\/\/doi.org\/10.3389\/fped.2022.973256","journal-title":"Front Pediatr"},{"key":"12183_CR14","doi-asserted-by":"publisher","first-page":"109022","DOI":"10.1016\/j.abb.2021.109022","volume":"711","author":"S Andrade","year":"2021","unstructured":"Andrade S, Loureiro JA, Pereira MDC (2021) Influence of in vitro neuronal membranes on the anti-amyloidogenic activity of gallic acid: Implication for the therapy of Alzheimer\u2019s disease. Arch Biochem Biophys 711:109022. https:\/\/doi.org\/10.1016\/j.abb.2021.109022","journal-title":"Arch Biochem Biophys"},{"key":"12183_CR15","doi-asserted-by":"publisher","first-page":"10304","DOI":"10.1039\/d4ra00766b","volume":"14","author":"F Hussain","year":"2024","unstructured":"Hussain F, Tahir A, Jan MS, Fatima N et al (2024) Exploitation of the multitarget role of new ferulic and gallic acid derivatives in oxidative stress-related Alzheimer\u2019s disease therapies: design, synthesis and bioevaluation. RSC Adv 14:10304\u201310321. https:\/\/doi.org\/10.1039\/d4ra00766b","journal-title":"RSC Adv"},{"key":"12183_CR16","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1538\/expanim.23-0165","volume":"73","author":"W Thong-Asa","year":"2024","unstructured":"Thong-Asa W, Wassana C, Sukkasem K, Innoi P et al (2024) Neuroprotective effect of gallic acid in mice with rotenone-induced neurodegeneration. Exp Anim 73:259\u2013269. https:\/\/doi.org\/10.1538\/expanim.23-0165","journal-title":"Exp Anim"},{"key":"12183_CR17","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1016\/j.neuro.2021.10.003","volume":"87","author":"Q Song","year":"2021","unstructured":"Song Q, Peng S, Zhu X (2021) Baicalein protects against MPP(+)\/MPTP-induced neurotoxicity by ameliorating oxidative stress in SH-SY5Y cells and mouse model of Parkinson\u2019s disease. Neurotoxicology 87:188\u2013194. https:\/\/doi.org\/10.1016\/j.neuro.2021.10.003","journal-title":"Neurotoxicology"},{"key":"12183_CR18","doi-asserted-by":"publisher","first-page":"1539","DOI":"10.2337\/diab.38.12.1539","volume":"38","author":"SK Jain","year":"1989","unstructured":"Jain SK, McVie R, Duett J, Herbst JJ (1989) Erythrocyte membrane lipid peroxidation and glycosylated hemoglobin in diabetes. Diabetes 38:1539\u20131543. https:\/\/doi.org\/10.2337\/diab.38.12.1539","journal-title":"Diabetes"},{"key":"12183_CR19","doi-asserted-by":"publisher","first-page":"905","DOI":"10.3724\/abbs.2024008","volume":"56","author":"C Chu","year":"2024","unstructured":"Chu C, Ru H, Chen Y, Xu J et al (2024) Gallic acid attenuates LPS-induced inflammation in Caco-2 cells by suppressing the activation of the NF-\u03baB\/MAPK signaling pathway. Acta Biochim Biophys Sin (Shanghai) 56:905\u2013915. https:\/\/doi.org\/10.3724\/abbs.2024008","journal-title":"Acta Biochim Biophys Sin (Shanghai)"},{"key":"12183_CR20","doi-asserted-by":"publisher","first-page":"1150","DOI":"10.1007\/s11064-018-2530-y","volume":"43","author":"Y Chandrasekhar","year":"2018","unstructured":"Chandrasekhar Y, Phani Kumar G, Ramya EM, Anilakumar KR (2018) Gallic Acid Protects 6-OHDA Induced Neurotoxicity by Attenuating Oxidative Stress in Human Dopaminergic Cell Line. Neurochem Res 43:1150\u20131160. https:\/\/doi.org\/10.1007\/s11064-018-2530-y","journal-title":"Neurochem Res"},{"key":"12183_CR21","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/j.msec.2015.11.014","volume":"60","author":"A de Cristo Soares Alves","year":"2016","unstructured":"de Cristo Soares Alves A, Mainardes RM, Khalil NM (2016) Nanoencapsulation of gallic acid and evaluation of its cytotoxicity and antioxidant activity. Mater Sci Eng C Mater Biol Appl 60:126\u2013134. https:\/\/doi.org\/10.1016\/j.msec.2015.11.014","journal-title":"Mater Sci Eng C Mater Biol Appl"},{"key":"12183_CR22","doi-asserted-by":"publisher","first-page":"1577","DOI":"10.1038\/s41598-023-28893-6","volume":"13","author":"OA Ojo","year":"2023","unstructured":"Ojo OA, Rotimi DE, Ojo AB, Ogunlakin AD, Ajiboye BO (2023) Gallic acid abates cadmium chloride toxicity via alteration of neurotransmitters and modulation of inflammatory markers in Wistar rats. Sci Rep 13:1577. https:\/\/doi.org\/10.1038\/s41598-023-28893-6","journal-title":"Sci Rep"},{"key":"12183_CR23","doi-asserted-by":"publisher","first-page":"91","DOI":"10.3389\/fnana.2015.00091","volume":"9","author":"J Blesa","year":"2015","unstructured":"Blesa J, Trigo-Damas I, Quiroga-Varela A, Jackson-Lewis VR (2015) Oxidative stress and Parkinson\u2019s disease. Front Neuroanat 9:91. https:\/\/doi.org\/10.3389\/fnana.2015.00091","journal-title":"Front Neuroanat"},{"key":"12183_CR24","doi-asserted-by":"publisher","first-page":"342","DOI":"10.3389\/fnins.2018.00342","volume":"12","author":"S Franco-Iborra","year":"2018","unstructured":"Franco-Iborra S, Vila M, Perier C (2018) Mitochondrial Quality Control in Neurodegenerative Diseases: Focus on Parkinson\u2019s Disease and Huntington\u2019s Disease. Front Neurosci 12:342. https:\/\/doi.org\/10.3389\/fnins.2018.00342","journal-title":"Front Neurosci"},{"key":"12183_CR25","doi-asserted-by":"publisher","first-page":"4431","DOI":"10.3892\/etm.2017.5049","volume":"14","author":"P Gong","year":"2017","unstructured":"Gong P, Deng F, Zhang W, Ji J et al (2017) Tectorigenin attenuates the MPP(+)-induced SH-SY5Y cell damage, indicating a potential beneficial role in Parkinson\u2019s disease by oxidative stress inhibition. Exp Ther Med 14:4431\u20134437. https:\/\/doi.org\/10.3892\/etm.2017.5049","journal-title":"Exp Ther Med"},{"key":"12183_CR26","doi-asserted-by":"publisher","first-page":"2129","DOI":"10.1007\/s11064-023-03880-5","volume":"48","author":"M Liu","year":"2023","unstructured":"Liu M, Zuo S, Guo X, Peng J et al (2023) The Study of Overexpression of Peroxiredoxin-2 Reduces MPP(+)-Induced Toxicity in the Cell Model of Parkinson\u2019s Disease. Neurochem Res 48:2129\u20132137. https:\/\/doi.org\/10.1007\/s11064-023-03880-5","journal-title":"Neurochem Res"},{"key":"12183_CR27","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1007\/s10571-025-01575-9","volume":"45","author":"Y Wen","year":"2025","unstructured":"Wen Y, Han Z, Wang B, Feng C et al (2025) Endoplasmic Reticulum Stress Inhibition Promotes Mitophagy via Miro1 Reduction to Rescue Mitochondrial Dysfunction and Protect Dopamine Neurons in Parkinson\u2019s Disease. Cell Mol Neurobiol 45:53. https:\/\/doi.org\/10.1007\/s10571-025-01575-9","journal-title":"Cell Mol Neurobiol"},{"key":"12183_CR28","doi-asserted-by":"publisher","unstructured":"Xicoy H, Wieringa B, Martens GJ (2017) The SH-SY5Y cell line in Parkinson\u2019s disease research: a systematic review. Mol Neurodegener 12(10). https:\/\/doi.org\/10.1186\/s13024-017-0149-0","DOI":"10.1186\/s13024-017-0149-0"},{"key":"12183_CR29","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.brainres.2010.03.102","volume":"1337","author":"FM Lopes","year":"2010","unstructured":"Lopes FM, Schr\u00f6der R, da Frota ML Jr., Zanotto-Filho A et al (2010) Comparison between proliferative and neuron-like SH-SY5Y cells as an in vitro model for Parkinson disease studies. Brain Res 1337:85\u201394. https:\/\/doi.org\/10.1016\/j.brainres.2010.03.102","journal-title":"Brain Res"},{"key":"12183_CR30","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.pneurobio.2013.04.004","volume":"106\u2013107","author":"SR Subramaniam","year":"2013","unstructured":"Subramaniam SR, Chesselet MF (2013) Mitochondrial dysfunction and oxidative stress in Parkinson\u2019s disease. Prog Neurobiol 106\u2013107:17\u201332. https:\/\/doi.org\/10.1016\/j.pneurobio.2013.04.004","journal-title":"Prog Neurobiol"},{"key":"12183_CR31","doi-asserted-by":"publisher","unstructured":"Szwajgier D, Borowiec K, Pustelniak K (2017) The neuroprotective effects of phenolic acids. Mol Mechanism Action Nutrients 9. https:\/\/doi.org\/10.3390\/nu9050477","DOI":"10.3390\/nu9050477"},{"key":"12183_CR32","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1038\/nrn2214","volume":"8","author":"V Calabrese","year":"2007","unstructured":"Calabrese V, Mancuso C, Calvani M, Rizzarelli E et al (2007) Nitric oxide in the central nervous system: neuroprotection versus neurotoxicity. Nat Rev Neurosci 8:766\u2013775. https:\/\/doi.org\/10.1038\/nrn2214","journal-title":"Nat Rev Neurosci"},{"key":"12183_CR33","doi-asserted-by":"publisher","unstructured":"Azargoonjahromi A (2023) Dual role of nitric oxide in Alzheimer\u2019s disease. Nitric Oxide 134\u201313523. https:\/\/doi.org\/10.1016\/j.niox.2023.03.003","DOI":"10.1016\/j.niox.2023.03.003"},{"key":"12183_CR34","doi-asserted-by":"publisher","first-page":"54","DOI":"10.4161\/oxim.1.1.6958","volume":"1","author":"V Lahaie-Collins","year":"2008","unstructured":"Lahaie-Collins V, Bournival J, Plouffe M, Carange J, Martinoli MG (2008) Sesamin modulates tyrosine hydroxylase, superoxide dismutase, catalase, inducible NO synthase and interleukin-6 expression in dopaminergic cells under MPP+-induced oxidative stress. Oxid Med Cell Longev 1:54\u201362. https:\/\/doi.org\/10.4161\/oxim.1.1.6958","journal-title":"Oxid Med Cell Longev"},{"key":"12183_CR35","doi-asserted-by":"publisher","first-page":"299","DOI":"10.31083\/j.jin.2019.03.127","volume":"18","author":"C Liu","year":"2019","unstructured":"Liu C, Fang J, Liu W (2019) Superoxide dismutase coding of gene polymorphisms associated with susceptibility to Parkinson\u2019s disease. J Integr Neurosci 18:299\u2013303. https:\/\/doi.org\/10.31083\/j.jin.2019.03.127","journal-title":"J Integr Neurosci"},{"key":"12183_CR36","doi-asserted-by":"publisher","unstructured":"Zhang Y, Zheng J, Zhang X, Zhang Y et al (2026) Oxidative stress in frailty among older adults: are malondialdehyde and superoxide dismutase the key biomarkers? Biogerontology, 27 56. https:\/\/doi.org\/10.1007\/s10522-026-10405-4","DOI":"10.1007\/s10522-026-10405-4"},{"key":"12183_CR37","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.ab.2016.10.021","volume":"524","author":"D Tsikas","year":"2017","unstructured":"Tsikas D (2017) Assessment of lipid peroxidation by measuring malondialdehyde (MDA) and relatives in biological samples: Analytical and biological challenges. Anal Biochem 524:13\u201330. https:\/\/doi.org\/10.1016\/j.ab.2016.10.021","journal-title":"Anal Biochem"},{"key":"12183_CR38","doi-asserted-by":"publisher","first-page":"225","DOI":"10.22038\/ijbms.2019.32806.7897","volume":"22","author":"N Kahkeshani","year":"2019","unstructured":"Kahkeshani N, Farzaei F, Fotouhi M, Alavi SS et al (2019) Pharmacological effects of gallic acid in health and diseases: A mechanistic review. Iran J Basic Med Sci 22:225\u2013237. https:\/\/doi.org\/10.22038\/ijbms.2019.32806.7897","journal-title":"Iran J Basic Med Sci"}],"container-title":["Molecular Biology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-026-12183-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11033-026-12183-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-026-12183-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T13:50:22Z","timestamp":1781877022000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11033-026-12183-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,19]]},"references-count":38,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,12]]}},"alternative-id":["12183"],"URL":"https:\/\/doi.org\/10.1007\/s11033-026-12183-1","relation":{},"ISSN":["0301-4851","1573-4978"],"issn-type":[{"value":"0301-4851","type":"print"},{"value":"1573-4978","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,19]]},"assertion":[{"value":"20 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"There is no problem in terms of research and publication ethics.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Statements"}}],"article-number":"967"}}